Long term safety and efficacy of open-label infliximab for SLE

被引：0
|
作者：
Aringer, M. [1 ]
Houssiau, F. [2 ,3 ]
Graninger, W. B. [4 ]
Feier, E. [5 ]
Steiner, G. [5 ]
Smolen, J. S. [5 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Tech Univ Dresden, Univ Clin Ctr Carl Gustav Carus, Dresden, Germany
[3] Univ Catholique Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[4] Med Univ Graz, Graz, Austria
[5] Med Univ Vienna, Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study
    Tanaka, Yoshiya
    Curtis, Paula
    DeRose, Kathleen
    Kurrasch, Regina
    Kinoshita, Kyoko
    Tanaka, Rika
    Yamazaki, Yumi
    Roth, David A.
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 122 - 133
  • [2] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [3] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [4] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    EPILEPSIA, 2005, 46 : 118 - 118
  • [5] An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
    Gahan Pandina
    Stuart Kushner
    Keith Karcher
    Magali Haas
    Child and Adolescent Psychiatry and Mental Health, 6 (1)
  • [6] Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia
    Hale, T.
    Murray, R. M.
    Azorin, J. M.
    Maehlum, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 431 - 432
  • [7] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [8] Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study
    Rigopoulos, D.
    Gregoriou, S.
    Stratigos, A.
    Larios, G.
    Korfitis, C.
    Papaioannou, D.
    Antoniou, C.
    Ioannides, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (02) : 453 - 456
  • [9] Safety and efficacy of infliximab therapy in active behcet’s uveitis: an open-label trial
    H. Al-Rayes
    R. Al-Swailem
    M. Al-Balawi
    N. Al-Dohayan
    S. Al-Zaidi
    M. Tariq
    Rheumatology International, 2008, 29 : 53 - 57
  • [10] Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial
    Al-Rayes, H.
    Al-Swailem, R.
    Al-Balawi, M.
    Al-Dohayan, N.
    Al-Zaidi, S.
    Tariq, M.
    RHEUMATOLOGY INTERNATIONAL, 2008, 29 (01) : 53 - 57
12345